5-Amino-1mq Research
5-Amino-1MQ is a selective, membrane-permeable small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) investigated for its role in cellular energy regulation. Preclinical studies suggest that targeted NNMT inhibition elevates intracellular NAD+ pools, enhances mitochondrial respiration, and modulates lipid accumulation in specialized cell cultures and animal models. This technical summary synthesizes current biochemical findings, handling protocols, and quality requirements for laboratory researchers.
Quick answer
5-Amino-1MQ is a selective, membrane-permeable small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) investigated for its role in cellular energy regulation. Preclinical studies suggest that targeted NNMT inhibition elevates intracellular NAD+ pools, enhances mitochondrial respiration, and modulates lipid accumulation in specialized cell cultures and animal models. This technical summary synthesizes current biochemical findings, handling protocols, and quality requirements for laboratory researchers.
Key takeaways
- In contemporary metabolic biochemistry, [5-amino-1MQ](/research-peptides/5-amino-1mq) (5-amino-1-methylquinolinium) represents a distinct quinolinium derivative synthesized to act as a potent, cell-permeable inhibitor of nicotinamide N-methyltransferase (NNMT).
- The fundamental biochemical target of [5-amino-1MQ](/research-peptides/5-amino-1mq) is NNMT, a cytosolic enzyme primarily expressed in adipose tissue, liver, and skeletal muscle cells.
- [NAD+](/research-peptides/nad-plus) functions as a critical coenzyme in mitochondrial electron transport, glycolytic processing, and the citric acid cycle.
- The impact of [5-amino-1MQ](/research-peptides/5-amino-1mq) on lipid accumulation and adipocyte morphology has been investigated extensively in diet-induced obesity rodent models.
Definition and Structural Classification of 5-Amino-1MQ
In contemporary metabolic biochemistry, 5-amino-1MQ (5-amino-1-methylquinolinium) represents a distinct quinolinium derivative synthesized to act as a potent, cell-permeable inhibitor of nicotinamide N-methyltransferase (NNMT). The molecule possesses a compact cationic structure that allows it to interact directly with the active binding pocket of the NNMT enzyme, blocking substrate access and suppressing methyl transfer kinetics.
While frequently categorized alongside metabolic peptides in experimental literature, 5-amino-1MQ is chemically classified as a small organic cation rather than a chain of amino acid residues. Nevertheless, researchers evaluating novel energy-regulating molecules frequently integrate 5-amino-1MQ alongside peptide-based signaling factors in broader cellular metabolic panels.
Investigators interested in sourcing validated reference standards for experimental protocols can evaluate 5-Amino-1MQ through PX1 Research's comprehensive catalog of laboratory compounds.
Molecular Mechanism: Inhibition of Nicotinamide N-Methyltransferase (NNMT)
The fundamental biochemical target of 5-amino-1MQ is NNMT, a cytosolic enzyme primarily expressed in adipose tissue, liver, and skeletal muscle cells. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). Because 1-MNA is excreted or further oxidized, this methylation reaction irreversibly removes nicotinamide from the salvage pathway required to synthesize nicotinamide adenine dinucleotide (NAD+).
In vitro assay data demonstrate that high NNMT expression correlates with depleted NAD+ availability and suppressed mitochondrial respiration. By competitively inhibiting NNMT, 5-amino-1MQ prevents the degradation of nicotinamide into 1-MNA. This enzymatic blockade rescues the substrate pool necessary for salvage-pathway NAD+ synthesis, thereby supporting higher physiological ratios of NAD+ to NADH within target tissue models.
Furthermore, because SAM serves as the universal methyl donor for histones and DNA methyltransferases, NNMT activity indirectly alters epigenomic regulation. Preclinical studies indicate that suppressing NNMT with 5-amino-1MQ alters cellular SAM/SAH dynamics, retaining methyl availability for epigenetic regulation while simultaneously driving cellular energy expenditure.
Impact on Cellular Energetics and Mitochondrial Output
NAD+ functions as a critical coenzyme in mitochondrial electron transport, glycolytic processing, and the citric acid cycle. When 5-amino-1MQ preserves intracellular NAD+ availability, preclinical models display a downstream upregulation of sirtuin-1 (SIRT1) and adenosine monophosphate-activated protein kinase (AMPK) signaling cascades. These energy-sensing enzymes play pivotal roles in stimulating mitochondrial biogenesis and promoting oxidative phosphorylation.
In vitro measurements utilizing oxygen consumption rate (OCR) assays reveal that adipocytes and myocytes treated with 5-amino-1MQ exhibit increased basal respiration and maximal respiratory capacity. This elevated mitochondrial output directly enhances the turnover of fatty acids, directing intracellular lipids toward beta-oxidation rather than storage.
For additional foundational concepts on how regulatory pathways modulate mitochondrial biogenesis and cellular respiration, researchers can consult the PX1 Research Library for technical monographs and analytical deep-dives.
Preclinical Findings: Fat Metabolism and Adipocyte Dynamics
The impact of 5-amino-1MQ on lipid accumulation and adipocyte morphology has been investigated extensively in diet-induced obesity rodent models. Preclinical studies demonstrate that high-fat diet rodent groups administered NNMT inhibitors show marked reductions in adipocyte hypertrophy without reductions in food intake, pointing to an intrinsic shift in basal metabolic rate rather than appetite suppression.
Cellular assays using 3T3-L1 adipocyte cultures indicate that exposure to 5-amino-1MQ inhibits lipogenesis and reduces lipid droplet accumulation during differentiation. These observations are accompanied by decreased transcript expression of key lipogenic markers, including peroxisome proliferator-activated receptor gamma (PPARγ) and fatty acid synthase (FAS).
Animal studies evaluating systemic metabolism further report improvements in insulin sensitivity, plasma lipid profiles, and liver triglyceride concentration following target NNMT inhibition. These results suggest that 5-amino-1MQ serves as a valuable chemical probe for dissecting the interplay between adipocyte energy expenditure, lipid storage, and systemic insulin responsiveness.
Comparative Analysis: 5-Amino-1MQ vs. Alternative Metabolic Compounds
To establish rigorous experimental design, investigators frequently compare 5-amino-1MQ with other regulatory research compounds targeting distinct pathways of energy homeostasis and lipid metabolism. While 5-amino-1MQ acts as a direct small-molecule enzyme inhibitor, peptide options engage cell-surface receptors or mitochondrial machinery to induce functional changes.
For example, MOTS-c is a mitochondrially derived peptide that translocates to the nucleus under metabolic stress to regulate folate purine biosynthesis and AMPK activation. Detailed comparisons of mitochondrial signaling mechanisms are documented in our review of MOTS-c mechanisms. Conversely, AOD-9604 is a C-terminal fragment of human growth hormone studied for lipolytic activity independent of growth pathways, as further detailed in our AOD-9604 preclinical review. Another comparator, Tesamorelin, functions as a growth hormone-releasing hormone (GHRH) analogue stimulating endogenous GH secretion to influence visceral fat composition.
While compounds like AOD-9604 and Tesamorelin rely on neuroendocrine or receptor-mediated lipolytic signaling cascades, 5-amino-1MQ operates entirely intracellularly by modulating enzyme kinetics, NAD+ salvage, and SAM methyl availability. Researchers can review all available metabolic compounds in our complete peptide catalog.
Reconstitution, Solubilization, and Laboratory Handling
Proper handling and solubilization are critical to maintain the structural stability and assay reproducibility of 5-amino-1MQ in vitro and in vivo. Unlike standard hydrophilic peptides, 5-amino-1MQ is a synthetic quinolinium salt exhibiting distinct solubility characteristics based on solvent polarity and pH.
For cell culture and enzymatic assays, 5-amino-1MQ is routinely reconstituted in dimethyl sulfoxide (DMSO) to prepare concentrated stock solutions (typically 10 mM to 50 mM). Gentle vortexing and mild sonication (1–2 minutes) may be employed to ensure complete dissolution. Stock solutions prepared in DMSO should be aliquoted under sterile conditions to avoid repeat freeze-thaw cycles and stored at -80°C for long-term stability.
For aqueous working preparations, stock solutions in DMSO can be diluted into sterile phosphate-buffered saline (PBS) or culture media immediately prior to application, keeping the final organic solvent concentration below 0.1% v/v to prevent vehicle cytotoxicity in vitro.
Analytical Verification: HPLC, Mass Spectrometry, and Endotoxin Standards
In modern preclinical research, subtle chemical impurities or residual heavy metals can confound enzymatic assays and cell viability metrics. To ensure unequivocal experimental consistency, PX1 Research subjects every synthesis lot of 5-amino-1MQ to stringent analytical verification.
Purity assessment is performed via High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS). Reversed-Phase HPLC (RP-HPLC) verifies chemical purity above 98.0%, ensuring the absence of unreacted precursor quinolines or degradation products. Mass spectrometry confirms the exact molecular mass and identity of the 5-amino-1methylquinolinium ion.
Furthermore, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to quantify bacterial endotoxin levels. PX1 Research enforces an industry-leading endotoxin limit of <0.5 EU/mg, protecting delicate primary cell lines and animal models from endotoxin-induced inflammatory responses. Comprehensive Certificate of Analysis (COA) documents accompany every batch.
Sourcing Verified 5-Amino-1MQ from USA Manufacturers
Reliable research outcomes depend upon consistent compound quality, traceable supply chains, and transparent manufacturing standards. Sourcing 5-amino-1MQ from non-verified overseas distributors introduces variability in potency, counter-ion balance, and chemical purity.
PX1 Research manufactures and processes compounds within state-of-the-art, GMP-compliant facilities located in the United States. Analytical testing is conducted in independent ISO 17025 accredited laboratories, providing full lot-level traceability for every shipment dispatched from our California and Arizona fulfillment centers.
Institutional laboratories, academic departments, and high-volume facilities seeking reliable fulfillment can establish direct commercial partnerships through our wholesale lab accounts program.
Frequently Asked Questions
What is the primary mechanism of 5-amino-1MQ in laboratory research?
5-Amino-1MQ acts as a membrane-permeable competitive inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT activity, it prevents the methylation of nicotinamide to 1-methylnicotinamide, preserving intracellular NAD+ levels and SAM pools in metabolic cell models.
How does 5-amino-1MQ differ from peptide-based metabolic research compounds?
5-Amino-1MQ is a synthetic small-molecule quinolinium derivative that acts directly inside the cytosol on enzyme kinetics. In contrast, metabolic research peptides like MOTS-c or AOD-9604 act via mitochondrial signaling pathways or extracellular cell-surface receptors.
What solvent is recommended for reconstituting 5-amino-1MQ?
For in vitro assay preparation, high-purity DMSO is recommended to prepare concentrated stock solutions (10–50 mM). These stocks can be diluted into aqueous buffers such as sterile PBS or cell culture media immediately before use.
How should 5-amino-1MQ be stored in the laboratory?
Lyophilized powder should be stored in a dry environment at -20°C, protected from light. Reconstituted DMSO stock solutions should be aliquoted and stored at -80°C to maintain stability and avoid freeze-thaw degradation.
What analytical purity standards are provided with 5-amino-1MQ from PX1 Research?
Every lot of 5-amino-1MQ supplied by PX1 Research is verified by RP-HPLC and Mass Spectrometry to guarantee chemical purity of ≥98.0%. Lot-specific Certificates of Analysis (COAs) are available for every shipment.
What is the endotoxin threshold for PX1 Research 5-amino-1MQ?
PX1 Research enforces a strict endotoxin threshold of <0.5 EU/mg, verified via chromogenic LAL assays in ISO 17025 accredited testing facilities.
Is 5-amino-1MQ approved for human administration or clinical therapy?
No. 5-Amino-1MQ is sold strictly as a laboratory research compound for in vitro assays, biochemical profiling, and preclinical animal research. It is not approved for human consumption, clinical diagnostic, or therapeutic use.
Where are PX1 Research compounds manufactured and shipped from?
PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment hubs in California and Arizona with same-day dispatch for weekday orders placed before cutoff.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.